Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Seminars in Immunopathology
Published in: Seminars in Immunopathology 2/2012

Open Access 01-03-2012 | Review

Neutrophils in innate host defense against Staphylococcus aureus infections

Authors: Kevin M. Rigby, Frank R. DeLeo

Published in: Seminars in Immunopathology | Issue 2/2012

Login to get access

Abstract

Staphylococcus aureus has been an important human pathogen throughout history and is currently a leading cause of bacterial infections worldwide. S. aureus has the unique ability to cause a continuum of diseases, ranging from minor skin infections to fatal necrotizing pneumonia. Moreover, the emergence of highly virulent, drug-resistant strains such as methicillin-resistant S. aureus in both healthcare and community settings is a major therapeutic concern. Neutrophils are the most prominent cellular component of the innate immune system and provide an essential primary defense against bacterial pathogens such as S. aureus. Neutrophils are rapidly recruited to sites of infection where they bind and ingest invading S. aureus, and this process triggers potent oxidative and non-oxidative antimicrobial killing mechanisms that serve to limit pathogen survival and dissemination. S. aureus has evolved numerous mechanisms to evade host defense strategies employed by neutrophils, including the ability to modulate normal neutrophil turnover, a process critical to the resolution of acute inflammation. Here we provide an overview of the role of neutrophils in host defense against bacterial pathogens and discuss strategies employed by S. aureus to circumvent neutrophil function.
Literature
1.
Smith G (1982) Ogston’s coccus: 102 years and still going strong. South Med J 75(12):1559–1562PubMedCrossRef
2.
3.
Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32(Suppl 2):S114–S132PubMedCrossRef
4.
Styers D, Sheehan DJ, Hogan P, Sahm DF (2006) Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 5:2PubMedCrossRef
5.
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771PubMedCrossRef
6.
7.
Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis 13(12):1840–1846PubMed
8.
Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M (2007) National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998–2003). Clin Infect Dis 45(9):1132–1140PubMedCrossRef
9.
Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ (2008) Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis 197(9):1226–1234PubMedCrossRef
10.
11.
Otto M (2010) Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 64:143–162PubMedCrossRef
12.
Deleo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated methicillin-resistant Staphylococcus aureus. Lancet 375(9725):1557–1568PubMedCrossRef
13.
DeLeo FR, Diep BA, Otto M (2009) Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 23(1):17–34PubMedCrossRef
14.
Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111(9):1265–1273PubMed
15.
Rammelkamp CH, Maxon T (1942) Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med 51(3):386–389
16.
Barber M, Rozwadowskadowzenko M (1948) Infection by penicillin-resistant staphylococci. Lancet 255(OCT23):641–644CrossRef
17.
Chambers HF, DeLeo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7(9):629–641PubMedCrossRef
18.
DeLeo FR, Chambers HF (2009) Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 119(9):2464–2474PubMedCrossRef
19.
Graves SF, Kobayashi SD, DeLeo FR (2010) Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence. J Mol Med 88(2):109–114PubMedCrossRef
20.
21.
Jevons MP, Rolinson GN, Knox R (1961) Celbenin-resistant staphylococci. Brit Med J 1(521):124CrossRef
22.
Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I (1994) Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13(1):50–55PubMedCrossRef
23.
Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clin Infect Dis 42(3):389–391PubMedCrossRef
24.
Jarvis WR, Schlosser J, Chinn RY, Tweeten S, Jackson M (2007) National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 35(10):631–637PubMedCrossRef
25.
Heron MP, Hoyert DL, Xu J, Scott C, Tejada-Vera B (2008) Deaths: preliminary data for 2006. Natl Vital Stat Rep 56:1–52
26.
Pantosti A, Sanchini A, Monaco M (2007) Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol 2(3):323–334PubMedCrossRef
27.
David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23(3):616–687PubMedCrossRef
28.
Maranan MC, Moreira B, Boyle-Vavra S, Daum RS (1997) Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am 11(4):813–849PubMedCrossRef
29.
Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279(8):593–598PubMedCrossRef
30.
Aiello AE, Lowy FD, Wright LN, Larson EL (2006) Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis 6(6):335–341PubMedCrossRef
31.
Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV (1998) Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 178(2):577–580PubMed
32.
Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Lin J, Phan TH, Carleton HA, McDougal LK, Tenover FC, Cohen DE, Mayer KH, Sensabaugh GF, Perdreau-Remington F (2008) Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 148(4):249–257PubMed
33.
Begier EM, Frenette K, Barrett NL, Mshar P, Petit S, Boxrud DJ, Watkins-Colwell K, Wheeler S, Cebelinski EA, Glennen A, Nguyen D, Hadler JL (2004) A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 39(10):1446–1453PubMedCrossRef
34.
Barr B, Felkner M, Diamond PM (2006) High school athletic departments as sentinel surveillance sites for community-associated methicillin-resistant staphylococcal infections. Tex Med 102:56–61PubMed
35.
Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal LK, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352(5):468–475PubMedCrossRef
36.
Coronado F, Nicholas JA, Wallace BJ, Kohlerschmidt DJ, Musser K, Schoonmaker-Bopp DJ, Zimmerman SM, Boller AR, Jernigan DB, Kacica MA (2007) Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community. Epidemiol Infect 135(3):492–501PubMedCrossRef
37.
Fontanilla JM, Kirkland KB, Talbot EA, Powell KE, Schwartzman JD, Goering RV, Parsonnet J (2010) Outbreak of skin infections in college football team members due to an unusual strain of community-acquired methicillin-susceptible Staphylococcus aureus. J Clin Microbiol 48(2):609–611PubMedCrossRef
38.
Jail LAC, Svcs LACDH (2003) Public health dispatch: Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002–2003 (Reprinted from MMWR, vol 52, pg 88, 2003). Jama J Am Med Assoc 289(11):1377CrossRef
39.
Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP, Minarcik JR, Crum NF, Ryan MA (2004) Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 42(9):4050–4053PubMedCrossRef
40.
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002–2003 (2003). MMWR Morb Mortal Wkly Rep 52(5):88
41.
Crum NF, Lee RU, Thornton SA, Stine OC, Wallace MR, Barrozo C, Keefer-Norris A, Judd S, Russell KL (2006) Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 119(11):943–951PubMedCrossRef
42.
Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed
43.
Deurenberg RH, Nulens E, Valvatne H, Sebastian S, Driessen C, Craeghs J, De Brauwer E, Heising B, Kraat YJ, Riebe J, Stals FS, Trienekens TA, Scheres J, Friedrich AW, van Tiel FH, Beisser PS, Stobberingh EE (2009) Cross-border dissemination of methicillin-resistant Staphylococcus aureus, Euregio Meuse-Rhin region. Emerg Infect Dis 15(5):727–734PubMedCrossRef
44.
Huang YC, Hwang KP, Chen PY, Chen CJ, Lin TY (2007) Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006. J Clin Microbiol 45(12):3992–3995PubMedCrossRef
45.
Nimmo GR, Coombs GW (2008) Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 31(5):401–410PubMedCrossRef
46.
Park SH, Park C, Yoo JH, Choi SM, Choi JH, Shin HH, Lee DG, Lee S, Kim J, Choi SE, Kwon YM, Shin WS (2009) Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infect Control Hosp Epidemiol 30(2):146–155PubMedCrossRef
47.
Gardella N, von Specht M, Cuirolo A, Rosato A, Gutkind G, Mollerach M (2008) Community-associated methicillin-resistant Staphylococcus aureus, eastern Argentina. Diagn Microbiol Infect Dis 62(3):343–347PubMedCrossRef
48.
Francois P, Harbarth S, Huyghe A, Renzi G, Bento M, Gervaix A, Pittet D, Schrenzel J (2008) Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993–2005. Emerg Infect Dis 14(2):304–307PubMedCrossRef
49.
Fang H, Hedin G, Li G, Nord CE (2008) Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000–2005. Clin Microbiol Infect 14(4):370–376PubMedCrossRef
50.
Conly JM, Johnston BL (2003) The emergence of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in Canada. Can J Infect Dis 14(5):249–251PubMed
51.
Laupland KB, Ross T, Gregson DB (2008) Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis 198(3):336–343PubMedCrossRef
52.
Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355(7):666–674PubMedCrossRef
53.
Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, Mason EO Jr (2005) Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 40(12):1785–1791PubMedCrossRef
54.
Mathews WC, Caperna JC, Barber RE, Torriani FJ, Miller LG, May S, McCutchan JA (2005) Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 40(2):155–160PubMedCrossRef
55.
Purcell K, Fergie J (2005) Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children’s Hospital. Arch Pediatr Adolesc Med 159(10):980–985PubMedCrossRef
56.
Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352(14):1436–1444PubMedCrossRef
57.
Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS, Enright MC, O’Hanlon SJ, Thomas JC, Perdreau-Remington F, Gordon S, Gunthorpe H, Jacobs R, Jensen P, Leoung G, Rumack JS, Chambers HF (2008) A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clin Infect Dis 46(11):1637–1646PubMedCrossRef
58.
Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352(14):1445–1453PubMedCrossRef
59.
Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, Finelli L, Beekmann SE, Polgreen PM, Gorwitz R, Hageman J (2009) Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 53(3):358–365PubMedCrossRef
60.
Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton–Valentine leukocidin genes. Clin Infect Dis 40(1):100–107PubMedCrossRef
61.
Gonzalez BE, Hulten KG, Dishop MK, Lamberth LB, Hammerman WA, Mason EO Jr, Kaplan SL (2005) Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 41(5):583–590PubMedCrossRef
62.
Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinivasan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, McDonald LC (2006) Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis 12(6):894–899PubMedCrossRef
63.
Buck JM, Como-Sabetti K, Harriman KH, Danila RN, Boxrud DJ, Glennen A, Lynfield R (2005) Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003. Emerg Infect Dis 11(10):1532–1538PubMed
64.
Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S (2002) A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186(9):1344–1347PubMedCrossRef
65.
Lee SM, Ender M, Adhikari R, Smith JM, Berger-Bachi B, Cook GM (2007) Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother 51(4):1497–1499PubMedCrossRef
66.
Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O’Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40(11):4289–4294PubMedCrossRef
67.
Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA, Jones A, Palazzolo-Ballance AM, Perdreau-Remington F, Sensabaugh GF, DeLeo FR, Chambers HF (2008) The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197(11):1523–1530PubMedCrossRef
68.
Collins J, Rudkin J, Recker M, Pozzi C, O’Gara JP, Massey RC (2010) Offsetting virulence and antibiotic resistance costs by MRSA. ISME J 4(4):577–584PubMedCrossRef
69.
Dinauer MC, Lekstrom-Himes JA, Dale DC (2000) Inherited neutrophil disorders: molecular basis and new therapies. Hematology Am Soc Hematol Educ Program, pp 303–318
70.
Nauseef WM, Clark RA (2010) Chapter 8: granulocytic phagocytes. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious disease, 7th edn. Elsevier/Churchill Livingsone, New York
71.
Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR (2006) Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194(12):1761–1770PubMedCrossRef
72.
Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, DeLeo FR (2005) Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175(6):3907–3919PubMed
73.
Bainton DF, Ullyot JL, Farquhar MG (1971) The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 134(4):907–934PubMedCrossRef
74.
Fliedner TM, Cronkite EP, Robertson JS (1964) Granulocytopoiesis. I. Senescence and random loss of neutrophilic granulocytes in human beings. Blood 24:402–414PubMed
75.
Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE, Wintrobe MM (1961) Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 40:989–995PubMedCrossRef
76.
Rossi F, Zatti M (1964) Changes in the metabolic pattern of polymorpho-nuclear leucocytes during phagocytosis. Br J Exp Pathol 45:548–559PubMed
77.
Babior BM, Kipnes RS, Curnutte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52(3):741–744PubMedCrossRef
78.
79.
Lehrer RI, Hanifin J, Cline MJ (1969) Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature 223(5201):78–79PubMedCrossRef
80.
Bainton DF, Farquhar MG (1968) Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. I. Histochemical staining of bone marrow smears. J Cell Biol 39(2):286–298PubMedCrossRef
81.
Segal AW, Abo A (1993) The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 18(2):43–47PubMedCrossRef
82.
83.
84.
85.
Southwick FS, Stossel TP (1983) Contractile proteins in leukocyte function. Semin Hematol 20(4):305–321PubMed
86.
Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89(10):3503–3521PubMed
87.
Schiffmann E, Corcoran BA, Wahl SM (1975) N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA 72(3):1059–1062PubMedCrossRef
88.
Snyderman R, Goetzl EJ (1981) Molecular and cellular mechanisms of leukocyte chemotaxis. Science 213(4510):830–837PubMedCrossRef
89.
Kaplan HB, Edelson HS, Friedman R, Weissmann G (1982) The roles of degranulation and superoxide anion generation in neutrophil aggregation. Biochim Biophys Acta 721(1):55–63PubMedCrossRef
90.
Smith RJ, Wierenga W, Iden SS (1980) Characteristics of N-formyl-methionyl-leucyl-phenylalanine as an inducer of lysosomal enzyme release from human neutrophils. Inflammation 4(1):73–88PubMedCrossRef
91.
O’Flaherty JT (1980) Involvement of bivalent cations and arachidonic acid in neutrophil aggregation. Inflammation 4(2):181–194PubMedCrossRef
92.
Korchak HM, Vienne K, Wilkenfeld C, Roberts C, Rich AM, Weissmann G (1985) The first seconds of neutrophil activation: phosphoinositides, protein kinase C, and calcium movements. Trans Assoc Am Physicians 98:224–232PubMed
93.
Andrews PC, Babior BM (1983) Endogenous protein phosphorylation by resting and activated human neutrophils. Blood 61(2):333–340PubMed
94.
Helfman DM, Appelbaum BD, Vogler WR, Kuo JF (1983) Phospholipid-sensitive Ca2+-dependent protein kinase and its substrates in human neutrophils. Biochem Biophys Res Commun 111(3):847–853PubMedCrossRef
95.
Juhl H, Nahas N, Esmann V (1982) Dephosphorylation of glycogen synthase from human polymorphonuclear leukocytes. Biochim Biophys Acta 704(3):509–514PubMedCrossRef
96.
Bokoch GM, Gilman AG (1984) Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin. Cell 39(2 Pt 1):301–308PubMedCrossRef
97.
Lad PM, Olson CV, Smiley PA (1985) Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin. Proc Natl Acad Sci USA 82(3):869–873PubMedCrossRef
98.
Korchak HM, Vosshall LB, Haines KA, Wilkenfeld C, Lundquist KF, Weissmann G (1988) Activation of the human neutrophil by calcium-mobilizing ligands. II. Correlation of calcium, diacyl glycerol, and phosphatidic acid generation with superoxide anion generation. J Biol Chem 263(23):11098–11105PubMed
99.
Dillon SB, Murray JJ, Uhing RJ, Snyderman R (1987) Regulation of inositol phospholipid and inositol phosphate metabolism in chemoattractant-activated human polymorphonuclear leukocytes. J Cell Biochem 35(4):345–359PubMedCrossRef
100.
Verghese MW, Smith CD, Snyderman R (1985) Potential role for a guanine nucleotide regulatory protein in chemoattractant receptor mediated polyphosphoinositide metabolism, Ca++ mobilization and cellular responses by leukocytes. Biochem Biophys Res Commun 127(2):450–457PubMedCrossRef
101.
Kennedy AD, DeLeo FR (2009) Neutrophil apoptosis and the resolution of infection. Immunol Res 43(1–3):25–61PubMedCrossRef
102.
Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, Musser JM, DeLeo FR (2003) Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 100(19):10948–10953PubMedCrossRef
103.
Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83(3):865–875PubMedCrossRef
104.
Savill JS, Henson PM, Haslett C (1989) Phagocytosis of aged human neutrophils by macrophages is mediated by a novel “charge-sensitive” recognition mechanism. J Clin Invest 84(5):1518–1527PubMedCrossRef
105.
Edwards SW, Moulding DA, Derouet M, Moots RJ (2003) Regulation of neutrophil apoptosis. Chem Immunol Allergy 83:204–224PubMedCrossRef
106.
Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR (2002) Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci USA 99(10):6901–6906PubMedCrossRef
107.
Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N (2004) The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 172(12):7684–7693PubMed
108.
Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11(8):519–531PubMedCrossRef
109.
Tobias JD, Schleien C (1991) Granulocyte transfusions—a review for the intensive-care physician. Anaesth Intensive Care 19(4):512–520PubMed
110.
Froland SS (1984) Bacterial infections in the compromised host. Scand J Infect Dis Suppl 43:7–16PubMed
111.
Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64(2):328–340PubMed
112.
Dale DC, Dt G, Wewerka JR, Bull JM, Chusid MJ (1979) Chronic neutropenia. Medicine (Baltimore) 58(2):128–144
113.
Weissman IL, Anderson DJ, Gage F (2001) Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 17:387–403PubMedCrossRef
114.
Rosenbauer F, Tenen DG (2007) Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 7(2):105–117PubMedCrossRef
115.
Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, Nielsen FC, Cowland JB, Borregaard N (2005) The transcriptional program of terminal granulocytic differentiation. Blood 105(4):1785–1796PubMedCrossRef
116.
Glasser L, Fiederlein RL (1987) Functional differentiation of normal human neutrophils. Blood 69(3):937–944PubMed
117.
Cramer E, Pryzwansky KB, Villeval JL, Testa U, Breton-Gorius J (1985) Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 65(2):423–432PubMed
118.
Csernok E, Ludemann J, Gross WL, Bainton DF (1990) Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener’s granulomatosis. Am J Pathol 137(5):1113–1120PubMed
119.
Ohlsson K, Olsson I (1974) The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem 42(2):519–527PubMedCrossRef
120.
Rice WG, Ganz T, Kinkade JM Jr, Selsted ME, Lehrer RI, Parmley RT (1987) Defensin-rich dense granules of human neutrophils. Blood 70(3):757–765PubMed
121.
Weiss J, Olsson I (1987) Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood 69(2):652–659PubMed
122.
Cieutat AM, Lobel P, August JT, Kjeldsen L, Sengelov H, Borregaard N, Bainton DF (1998) Azurophilic granules of human neutrophilic leukocytes are deficient in lysosome-associated membrane proteins but retain the mannose 6-phosphate recognition marker. Blood 91(3):1044–1058PubMed
123.
Dahms NM, Lobel P, Kornfeld S (1989) Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 264(21):12115–12118PubMed
124.
Michaelson D, Rayner J, Couto M, Ganz T (1992) Cationic defensins arise from charge-neutralized propeptides: a mechanism for avoiding leukocyte autocytotoxicity? J Leukoc Biol 51(6):634–639PubMed
125.
Nauseef WM, McCormick S, Yi H (1992) Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 80(10):2622–2633PubMed
126.
Calafat J, Kuijpers TW, Janssen H, Borregaard N, Verhoeven AJ, Roos D (1993) Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood 81(11):3122–3129PubMed
127.
Borregaard N, Heiple JM, Simons ER, Clark RA (1983) Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 97(1):52–61PubMedCrossRef
128.
Sengelov H, Boulay F, Kjeldsen L, Borregaard N (1994) Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J 299(Pt 2):473–479PubMed
129.
Singer II, Scott S, Kawka DW, Kazazis DM (1989) Adhesomes: specific granules containing receptors for laminin, C3bi/fibrinogen, fibronectin, and vitronectin in human polymorphonuclear leukocytes and monocytes. J Cell Biol 109(6 Pt 1):3169–3182PubMedCrossRef
130.
Porteu F, Nathan CF (1992) Mobilizable intracellular pool of p55 (type I) tumor necrosis factor receptors in human neutrophils. J Leukoc Biol 52(1):122–124PubMed
131.
Sengelov H, Kjeldsen L, Kroeze W, Berger M, Borregaard N (1994) Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils. J Immunol 153(2):804–810PubMed
132.
Borregaard N, Kjeldsen L, Sengelov H, Diamond MS, Springer TA, Anderson HC, Kishimoto TK, Bainton DF (1994) Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 56(1):80–87PubMed
133.
Sengelov H, Kjeldsen L, Diamond MS, Springer TA, Borregaard N (1993) Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils. J Clin Invest 92(3):1467–1476PubMedCrossRef
134.
Masson PL, Heremans JF, Schonne E (1969) Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 130(3):643–658PubMedCrossRef
135.
Lazarus GS, Brown RS, Daniels JR, Fullmer HM (1968) Human granulocyte collagenase. Science 159(3822):1483–1485CrossRef
136.
Murphy G, Reynolds JJ, Bretz U, Baggiolini M (1977) Collagenase is a component of the specific granules of human neutrophil leucocytes. Biochem J 162(1):195–197PubMed
137.
Cline MJ (1975) Production, destruction, and distribution of neutrophilic granulocytes. The White Cell. Harvard University Press, Cambridge
138.
139.
Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, Imanishi J, Akashi K, Tenen DG (2006) C/EBPbeta is required for ‘emergency’ granulopoiesis. Nat Immunol 7(7):732–739PubMedCrossRef
140.
Panopoulos AD, Watowich SS (2008) Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine 42(3):277–288PubMedCrossRef
141.
Lawrence MB, Springer TA (1991) Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65(5):859–873PubMedCrossRef
142.
Richter Y, Groothuis A, Seifert P, Edelman ER (2004) Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. J Clin Invest 113(11):1607–1614PubMed
143.
Ley K, Zarbock A (2009) Neutrophil adhesion and activation under flow. Microcirculation 16(1):31–42PubMedCrossRef
144.
Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, VanOtteren GM, Strieter RM (1994) Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun 62(1):119–125PubMed
145.
Soell M, Diab M, Haan-Archipoff G, Beretz A, Herbelin C, Poutrel B, Klein JP (1995) Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun 63(4):1380–1386PubMed
146.
Yao L, Lowy FD, Berman JW (1996) Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells. Infect Immun 64(8):3407–3409PubMed
147.
Krakauer T (1998) Interleukin-8 production by human monocytic cells in response to staphylococcal exotoxins is direct and independent of interleukin-1 and tumor necrosis factor-alpha. J Infect Dis 178(2):573–577PubMed
148.
McLoughlin RM, Solinga RM, Rich J, Zaleski KJ, Cocchiaro JL, Risley A, Tzianabos AO, Lee JC (2006) CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci USA 103(27):10408–10413PubMedCrossRef
149.
Tzianabos AO, Wang JY, Lee JC (2001) Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci USA 98(16):9365–9370PubMedCrossRef
150.
Schmeling DJ, Peterson PK, Hammerschmidt DE, Kim Y, Verhoef J, Wilkinson BJ, Quie PG (1979) Chemotaxigenesis by cell surface components of Staphylococcus aureus. Infect Immun 26(1):57–63PubMed
151.
Showell HJ, Freer RJ, Zigmond SH, Schiffmann E, Aswanikumar S, Corcoran B, Becker EL (1976) The structure–activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med 143(5):1154–1169PubMedCrossRef
152.
Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13(12):1510–1514PubMedCrossRef
153.
McPhail LC, Clayton CC, Snyderman R (1984) The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J Biol Chem 259(9):5768–5775PubMed
154.
Kobayashi SD, Voyich JM, Burlak C, DeLeo FR (2005) Neutrophils in the innate immune response. Arch Immunol Ther Exp (Warsz) 53(6):505–517
155.
DeLeo FR, Renee J, McCormick S, Nakamura M, Apicella M, Weiss JP, Nauseef WM (1998) Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 101(2):455–463PubMedCrossRef
156.
Tedder TF, Penta AC, Levine HB, Freedman AS (1990) Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 144(2):532–540PubMed
157.
Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF, McEver RP (1995) P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 128(4):661–671PubMedCrossRef
158.
159.
von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC (1991) Two-step model of leukocyte–endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci USA 88(17):7538–7542CrossRef
160.
Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7(9):678–689PubMedCrossRef
161.
Muller WA, Weigl SA, Deng X, Phillips DM (1993) PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178(2):449–460PubMedCrossRef
162.
Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA (1990) ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111(6 Pt 2):3129–3139PubMedCrossRef
163.
Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, Ruffell B, Johnson P, Kubes P (2004) Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 173(12):7594–7601PubMed
164.
Cooper D, Lindberg FP, Gamble JR, Brown EJ, Vadas MA (1995) Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci USA 92(9):3978–3982PubMedCrossRef
165.
Takeuchi O, Hoshino K, Akira S (2000) Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165(10):5392–5396PubMed
166.
Kanneganti TD, Lamkanfi M, Nunez G (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27(4):549–559PubMedCrossRef
167.
van de Wetering JK, van Golde LM, Batenburg JJ (2004) Collectins: players of the innate immune system. Eur J Biochem 271(7):1229–1249PubMedCrossRef
168.
Fujita T, Matsushita M, Endo Y (2004) The lectin-complement pathway—its role in innate immunity and evolution. Immunol Rev 198:185–202PubMedCrossRef
169.
Hansen S, Holm D, Moeller V, Vitved L, Bendixen C, Reid KB, Skjoedt K, Holmskov U (2002) CL-46, a novel collectin highly expressed in bovine thymus and liver. J Immunol 169(10):5726–5734PubMed
170.
Liu C, Xu Z, Gupta D, Dziarski R (2001) Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J Biol Chem 276(37):34686–34694PubMedCrossRef
171.
Dziarski R, Platt KA, Gelius E, Steiner H, Gupta D (2003) Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice. Blood 102(2):689–697PubMedCrossRef
172.
Liu C, Gelius E, Liu G, Steiner H, Dziarski R (2000) Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J Biol Chem 275(32):24490–24499PubMedCrossRef
173.
Underhill DM, Gantner B (2004) Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbe Infect 6(15):1368–1373CrossRef
174.
Kennedy AD, Willment JA, Dorward DW, Williams DL, Brown GD, DeLeo FR (2007) Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 37(2):467–478PubMedCrossRef
175.
Brouwer N, Dolman KM, van Houdt M, Sta M, Roos D, Kuijpers TW (2008) Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J Immunol 180(6):4124–4132PubMed
176.
Fleit HB, Wright SD, Unkeless JC (1982) Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci USA 79(10):3275–3279PubMedCrossRef
177.
Mantovani B (1975) Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes. J Immunol 115(1):15–17PubMed
178.
Gounni AS, Lamkhioued B, Koussih L, Ra C, Renzi PM, Hamid Q (2001) Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma. FASEB J 15(6):940–949PubMedCrossRef
179.
Mansfield PJ, Hinkovska-Galcheva V, Carey SS, Shayman JA, Boxer LA (2002) Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. Blood 99(4):1434–1441PubMedCrossRef
180.
Albrechtsen M, Yeaman GR, Kerr MA (1988) Characterization of the IgA receptor from human polymorphonuclear leucocytes. Immunology 64(2):201–205PubMed
181.
Eggleton P, Ghebrehiwet B, Sastry KN, Coburn JP, Zaner KS, Reid KB, Tauber AI (1995) Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J Clin Invest 95(4):1569–1578PubMedCrossRef
182.
Rabellino EM, Ross GD, Polley MJ (1978) Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3. J Immunol 120(3):879–885PubMed
183.
Ross GD, Jarowski CI, Rabellino EM, Winchester RJ (1978) The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils. J Exp Med 147(3):730–744PubMedCrossRef
184.
Hickstein DD, Ozols J, Williams SA, Baenziger JU, Locksley RM, Roth GJ (1987) Isolation and characterization of the receptor on human neutrophils that mediates cellular adherence. J Biol Chem 262(12):5576–5580PubMed
185.
Dana N, Todd RF 3rd, Pitt J, Springer TA, Arnaout MA (1984) Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest 73(1):153–159PubMedCrossRef
186.
Myones BL, Dalzell JG, Hogg N, Ross GD (1988) Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest 82(2):640–651PubMedCrossRef
187.
Lee WL, Harrison RE, Grinstein S (2003) Phagocytosis by neutrophils. Microbes Infect 5(14):1299–1306PubMedCrossRef
188.
Hallett MB, Dewitt S (2007) Ironing out the wrinkles of neutrophil phagocytosis. Trends Cell Biol 17(5):209–214PubMedCrossRef
189.
Borjesson DL, Kobayashi SD, Whitney AR, Voyich JM, Argue CM, Deleo FR (2005) Insights into pathogen immune evasion mechanisms: anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J Immunol 174(10):6364–6372PubMed
190.
Kobayashi SD, Voyich JM, Braughton KR, DeLeo FR (2003) Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes. J Immunol 170(6):3357–3368PubMed
191.
Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA (2000) The neutrophil as a cellular source of chemokines. Immunol Rev 177:195–203PubMedCrossRef
192.
Quinn MT, Ammons MC, Deleo FR (2006) The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci (Lond) 111(1):1–20CrossRef
193.
Clark RA, Volpp BD, Leidal KG, Nauseef WM (1990) Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 85(3):714–721PubMedCrossRef
194.
DeLeo FR, Allen LA, Apicella M, Nauseef WM (1999) NADPH oxidase activation and assembly during phagocytosis. J Immunol 163(12):6732–6740PubMed
195.
Heyworth PG, Bohl BP, Bokoch GM, Curnutte JT (1994) Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavocytochrome b558. J Biol Chem 269(49):30749–30752PubMed
196.
Volpp BD, Nauseef WM, Clark RA (1988) Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 242(4883):1295–1297PubMedCrossRef
197.
Klebanoff SJ (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95(6):2131–2138PubMed
198.
Rosen H, Klebanoff SJ (1977) Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J Biol Chem 252(14):4803–4810PubMed
199.
Marcinkiewicz J (1997) Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 18(12):577–580PubMedCrossRef
200.
201.
Rada BK, Geiszt M, Hably C, Ligeti E (2005) Consequences of the electrogenic function of the phagocytic NADPH oxidase. Philos Trans R Soc Lond B Biol Sci 360(1464):2293–2300PubMedCrossRef
202.
DeCoursey TE, Cherny VV, Zhou W, Thomas LL (2000) Simultaneous activation of NADPH oxidase-related proton and electron currents in human neutrophils. Proc Natl Acad Sci USA 97(12):6885–6889PubMedCrossRef
203.
Lomax KJ, Leto TL, Nunoi H, Gallin JI, Malech HL (1989) Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245(4916):409–412PubMedCrossRef
204.
Matute JD, Arias AA, Dinauer MC, Patino PJ (2005) p40phox: the last NADPH oxidase subunit. Blood Cells Mol Dis 35(2):291–302PubMedCrossRef
205.
Bissonnette SA, Glazier CM, Stewart MQ, Brown GE, Ellson CD, Yaffe MB (2008) Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase. J Biol Chem 283(4):2108–2119PubMedCrossRef
206.
Tian W, Li XJ, Stull ND, Ming W, Suh CI, Bissonnette SA, Yaffe MB, Grinstein S, Atkinson SJ, Dinauer MC (2008) Fc gamma R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome. Blood 112(9):3867–3877PubMedCrossRef
207.
McPhail LC (1994) SH3-dependent assembly of the phagocyte NADPH oxidase. J Exp Med 180(6):2011–2015PubMedCrossRef
208.
Leto TL, Adams AG, de Mendez I (1994) Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc Natl Acad Sci USA 91(22):10650–10654PubMedCrossRef
209.
Lekstrom-Himes JA, Gallin JI (2000) Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 343(23):1703–1714PubMedCrossRef
210.
Nauseef WM (1990) Myeloperoxidase deficiency. Hematol Pathol 4(4):165–178PubMed
211.
Rosen H, Klebanoff SJ (1979) Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte. J Exp Med 149(1):27–39PubMedCrossRef
212.
Odell EW, Segal AW (1988) The bactericidal effects of the respiratory burst and the myeloperoxidase system isolated in neutrophil cytoplasts. Biochim Biophys Acta 971(3):266–274PubMedCrossRef
213.
Klebanoff SJ (1970) Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 169(950):1095–1097PubMedCrossRef
214.
Nauseef WM (2007) How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219:88–102PubMedCrossRef
215.
Faurschou M, Borregaard N (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5(14):1317–1327PubMedCrossRef
216.
Hirsch JG, Cohn ZA (1960) Degranulation of polymorphonuclear leucocytes following phagocytosis of microorganisms. J Exp Med 112:1005–1014PubMedCrossRef
217.
Oram JD, Reiter B (1968) Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta 170(2):351–365PubMedCrossRef
218.
Cohen MS, Britigan BE, Hassett DJ, Rosen GM (1988) Phagocytes, O2 reduction, and hydroxyl radical. Rev Infect Dis 10(6):1088–1096PubMedCrossRef
219.
Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP (2008) Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319(5865):962–965PubMedCrossRef
220.
Femling JK, Nauseef WM, Weiss JP (2005) Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils. J Immunol 175(7):4653–4661PubMed
221.
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532–1535PubMedCrossRef
222.
Papayannopoulos V, Zychlinsky A (2009) NETs: a new strategy for using old weapons. Trends Immunol 30(11):513–521PubMedCrossRef
223.
von Kockritz-Blickwede M, Nizet V (2009) Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med (Berl) 87(8):775–783CrossRef
224.
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176(2):231–241PubMedCrossRef
225.
Cohen JJ, Duke RC, Fadok VA, Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267–293PubMedCrossRef
226.
227.
Savill J (1997) Apoptosis in resolution of inflammation. J Leukoc Biol 61(4):375–380PubMed
228.
Shi J, Gilbert GE, Kokubo Y, Ohashi T (2001) Role of the liver in regulating numbers of circulating neutrophils. Blood 98(4):1226–1230PubMedCrossRef
229.
Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN (1996) A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5(6):653–666PubMedCrossRef
230.
Gamberale R, Giordano M, Trevani AS, Andonegui G, Geffner JR (1998) Modulation of human neutrophil apoptosis by immune complexes. J Immunol 161(7):3666–3674PubMed
231.
Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80(8):2012–2020PubMed
232.
Engelich G, White M, Hartshorn KL (2001) Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol 69(1):50–56PubMed
233.
Watson RW, Redmond HP, Wang JH, Bouchier-Hayes D (1996) Bacterial ingestion, tumor necrosis factor-alpha, and heat induce programmed cell death in activated neutrophils. Shock 5(1):47–51PubMedCrossRef
234.
Whyte MK, Meagher LC, MacDermot J, Haslett C (1993) Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150(11):5124–5134PubMed
235.
Fadok VA, Bratton DL, Henson PM (2001) Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 108(7):957–962PubMed
236.
Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390(6658):350–351PubMedCrossRef
237.
Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109(1):41–50PubMed
238.
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101(4):890–898PubMedCrossRef
239.
Li MO, Sarkisian MR, Mehal WZ, Rakic P, Flavell RA (2003) Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302(5650):1560–1563PubMedCrossRef
240.
Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56–59PubMedCrossRef
241.
O’Riordan K, Lee JC (2004) Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 17(1):218–234PubMedCrossRef
242.
Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H, Laufs R (1996) The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 178(1):175–183PubMed
243.
Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M (2004) A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279(52):54881–54886PubMedCrossRef
244.
Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M (2004) Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6(3):269–275PubMedCrossRef
245.
Forsgren A, Nordstrom K (1974) Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci 236:252–266PubMedCrossRef
246.
Langone JJ (1982) Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol 32:157–252PubMedCrossRef
247.
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199(5):687–695PubMedCrossRef
248.
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6(9):920–927PubMedCrossRef
249.
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V (2005) Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202(2):209–215PubMedCrossRef
250.
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48(12):4673–4679PubMedCrossRef
251.
Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66(5):1136–1147PubMedCrossRef
252.
Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M (2007) Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci USA 104(22):9469–9474PubMedCrossRef
253.
Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193(9):1067–1076PubMedCrossRef
254.
Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274(13):8405–8410PubMedCrossRef
255.
Joubert O, Voegelin J, Guillet V, Tranier S, Werner S, Colin DA, Serra MD, Keller D, Monteil H, Mourey L, Prevost G (2007) Distinction between pore assembly by staphylococcal alpha-toxin versus leukotoxins. J Biomed Biotechnol 2007(1):25935PubMed
256.
McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55:77–104PubMedCrossRef
257.
Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13(1):16–34, table of contentsPubMedCrossRef
258.
Yoshiie K, Kim HY, Mott J, Rikihisa Y (2000) Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 68(3):1125–1133PubMedCrossRef
259.
Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, Kristosturyan E, Whitney AR, Sturdevant DE, Dorward DW, Holland SM, Kreiswirth BN, Musser JM, DeLeo FR (2010) Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2(6):560–575PubMedCrossRef
260.
Bhakdi S, Tranum-Jensen J (1991) Alpha-toxin of Staphylococcus aureus. Microbiol Rev 55(4):733–751PubMed
261.
Valeva A, Walev I, Pinkernell M, Walker B, Bayley H, Palmer M, Bhakdi S (1997) Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci USA 94(21):11607–11611PubMedCrossRef
262.
Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O (2007) Poring over pores: alpha-hemolysin and Panton–Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13(12):1405–1406PubMedCrossRef
263.
Bubeck Wardenburg J, Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205(2):287–294PubMedCrossRef
264.
Bartlett AH, Foster TJ, Hayashida A, Park PW (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 198(10):1529–1535PubMedCrossRef
265.
Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS (2008) Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198(4):561–570PubMedCrossRef
266.
Burlak C, Hammer CH, Robinson MA, Whitney AR, McGavin MJ, Kreiswirth BN, Deleo FR (2007) Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol 9(5):1172–1190PubMedCrossRef
267.
Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, Bubeck Wardenburg J, Schneewind O, Otto M, Deleo FR (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204(6):937–941PubMedCrossRef
268.
Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, DeLeo FR (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202(7):1050–1058PubMedCrossRef
269.
Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 106(14):5883–5888PubMedCrossRef
270.
Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367(9512):731–739PubMedCrossRef
271.
272.
Montgomery CP, Boyle-Vavra S, Daum RS (2009) The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect Immun 77(7):2650–2656PubMedCrossRef
273.
Kaneko J, Kimura T, Narita S, Tomita T, Kamio Y (1998) Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton–Valentine leukocidin genes. Gene 215(1):57–67PubMedCrossRef
274.
Meyer F, Girardot R, Piemont Y, Prevost G, Colin DA (2009) Analysis of the specificity of Panton–Valentine leucocidin and gamma-hemolysin F component binding. Infect Immun 77(1):266–273PubMedCrossRef
275.
Colin DA, Mazurier I, Sire S, Finck-Barbancon V (1994) Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect Immun 62(8):3184–3188PubMed
276.
Konig B, Prevost G, Piemont Y, Konig W (1995) Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 171(3):607–613PubMedCrossRef
277.
Woodin AM, Wieneke AA (1964) The participation of calcium, adenosine triphosphate and adenosine triphosphatase in the extrusion of the granule proteins from the polymorphonuclear leucocyte. Biochem J 90(3):498–509PubMed
278.
Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S, Thivolet F, Etienne J, Lina G, Vallette FM, Vandenesch F, Genestier L (2005) Staphylococcus aureus Panton–Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115(11):3117–3127PubMedCrossRef
279.
Colin DA, Monteil H (2003) Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 71(7):3724–3729PubMedCrossRef
280.
Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29(5):1128–1132PubMedCrossRef
281.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D, Etienne J (2002) Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308):753–759PubMedCrossRef
282.
Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, Floret D, Etienne J (2007) Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton–Valentine leukocidin. Clin Infect Dis 45(3):315–321PubMedCrossRef
283.
Roundtree PaF V (1956) Infections caused by a particular phage type of Staphylococcus aureus. Med J Aust 42:157–161
284.
Tseng CW, Kyme P, Low J, Rocha MA, Alsabeh R, Miller LG, Otto M, Arditi M, Diep BA, Nizet V, Doherty TM, Beenhouwer DO, Liu GY (2009) Staphylococcus aureus Panton–Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One 4(7):e6387PubMedCrossRef
285.
Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR, Chambers HF (2008) Contribution of Panton–Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One 3(9):e3198PubMedCrossRef
286.
Montgomery CP, Daum RS (2009) Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for Panton–Valentine leukocidin? Infect Immun 77(5):2159–2167PubMedCrossRef
287.
Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR (2008) Panton–Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 198(8):1166–1170PubMedCrossRef
288.
Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, Vazquez V, Etienne J, Lina G, Vandenesch F, Bowden MG (2009) The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15(2):156–164CrossRef
289.
Graves SF, Kobayashi SD, Braughton KR, Diep BA, Chambers HF, Otto M, Deleo FR (2010) Relative contribution of Panton–Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants. Microbe Infect 12(6):446–456CrossRef
290.
Szmigielski S, Prevost G, Monteil H, Colin DA, Jeljaszewicz J (1999) Leukocidal toxins of staphylococci. Zentralbl Bakteriol 289(2):185–201PubMedCrossRef
291.
Lipinska U, Hermans K, Meulemans L, Dumitrescu O, Badiou C, Duchateau L, Haesebrouck F, Etienne J, Lina G (2011) Panton–Valentine leukocidin does play a role in the early stage of staphylococcus aureus skin infections: a rabbit model. PLoS One 6(8):e22864PubMedCrossRef
292.
Ventura CL, Malachowa N, Hammer CH, Nardone GA, Robinson MA, Kobayashi SD, DeLeo FR (2010) Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One 5(7):e11634PubMedCrossRef
293.
Bonilla FA, Geha RS (2003) 12. Primary immunodeficiency diseases. J Allergy Clin Immunol 111(2 Suppl):S571–S581PubMedCrossRef
294.
Lim MS, Elenitoba-Johnson KS (2004) The molecular pathology of primary immunodeficiencies. J Mol Diagn 6(2):59–83PubMedCrossRef
295.
Kumar A, Teuber SS, Gershwin ME (2006) Current perspectives on primary immunodeficiency diseases. Clin Dev Immunol 13(2–4):223–259PubMedCrossRef
296.
Bernini JC (1996) Diagnosis and management of chronic neutropenia during childhood. Pediatr Clin North Am 43(3):773–792PubMedCrossRef
297.
Schaffer AC, Lee JC (2009) Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 23(1):153–171PubMedCrossRef
298.
DeLeo FR, Otto M (2008) An antidote for Staphylococcus aureus pneumonia? J Exp Med 205(2):271–274PubMedCrossRef
299.
Otto M (2008) Targeted immunotherapy for staphylococcal infections: focus on anti-MSCRAMM antibodies. Bio Drugs 22(1):27–36
Metadata
Title
Neutrophils in innate host defense against Staphylococcus aureus infections
Authors
Kevin M. Rigby
Frank R. DeLeo
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Seminars in Immunopathology / Issue 2/2012
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-011-0295-3

Other articles of this Issue 2/2012

Seminars in Immunopathology 2/2012 Go to the issue

Review

Innate and adaptive immune responses against Staphylococcus aureus skin infections

Review

Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity

Introduction

Staphylococcus aureus: an introduction

Review

Exploring Staphylococcus aureus pathways to disease for vaccine development

Review

Targeting the host–pathogen interface for treatment of Staphylococcus aureus infection

Review

Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits